Info@ThinkPinkRocks.com

Study Suggests Targeted Drug Is a Potential Therapy for Rare Joint Disorder PVNS

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

View article:
Study Suggests Targeted Drug Is a Potential Therapy for Rare Joint Disorder PVNS

Share

Leave a Reply

Solve : *
3 + 3 =